Skip to content
Recall Observatory FDA recall evidence

Drug product

NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health

D-0065-2026

July 30, 2025

Class II

Product summary

Firm
GenoGenix LLC
Event
Event 97369
Status
Ongoing
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0065-2026

Official wording

Reason: Lack of Assurance of Sterility

Code information: All lots within expiry.

Distribution pattern: US Nationwide.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility